A B S T R A C T A gel filtration fraction of serum from chronically uremic patients has been shown previously to produce natriuresis in the rat. In the present studies, the same fraction from urine of uremic patients and normal subjects was studied for its natriuretic activity. Urine samples were obtained from 17 chronically uremic patients (mean glomerular filtration rate [GFR], 8.7 ml/min; mean fractional sodium excretion [FEN.], 5.7%), and 14 normal subjects. The fraction from the uremic patients produced a significant increase in absolute sodium excretion (UNaV) and FEN.; the fraction from normal subjects had no statistically significant effect on either UNNV or FENa; and the difference between the response to the uremic vs. normal fractions was highly significant for both parameters of sodium excretion. When a more concentrated urine fraction from uremic patients was administered, a striking natriuresis was observed with values for FEN. rising to levels as high as 12%. Studies also were performed on eight patients with far advanced chronic renal insufficiency and the nephrotic syndrome. The serum fraction was studied in each of these patients and the urine fraction in three. For the group, UNaV in the assay rats decreased by 0.87 iueq/min and FENa decreased by 1.35% after infusion of the serum fraction. These results differ significantly from those of patients with chronic uremia without the nephrotic syndrome. The data are consistent with the Parts of this work have been published in abstracted forms (7, 8) .
A B S T R A C T A gel filtration fraction of serum from chronically uremic patients has been shown previously to produce natriuresis in the rat. In the present studies, the same fraction from urine of uremic patients and normal subjects was studied for its natriuretic activity. Urine samples were obtained from 17 chronically uremic patients (mean glomerular filtration rate [GFR], 8.7 ml/min; mean fractional sodium excretion [FEN.], 5.7%), and 14 normal subjects. The fraction from the uremic patients produced a significant increase in absolute sodium excretion (UNaV) and FEN.; the fraction from normal subjects had no statistically significant effect on either UNNV or FENa; and the difference between the response to the uremic vs. normal fractions was highly significant for both parameters of sodium excretion. When a more concentrated urine fraction from uremic patients was administered, a striking natriuresis was observed with values for FEN. rising to levels as high as 12%. Studies also were performed on eight patients with far advanced chronic renal insufficiency and the nephrotic syndrome. The serum fraction was studied in each of these patients and the urine fraction in three. For the group, UNaV in the assay rats decreased by 0.87 iueq/min and FENa decreased by 1.35% after infusion of the serum fraction. These results differ significantly from those of patients with chronic uremia without the nephrotic syndrome. The data are consistent with the INTRODUCTION The inhibitor of sodium transport which has been found in the serum of patients with chronic uremia has been presumed to be a component part of the control system regulating sodium excretion, and to play a role in* the genesis of the progressive natriuresis per nephron that occurs in patients with advancing chronic renal disease (1) . However, the natriuretic factor could also be a nonspecific toxic substance, which is retained in the blood of uremic patients because of failure of excretion, and which bears no relation to the dictates of sodium balance. In the latter event, the rate of excretion of the factor in the urine should be no greater in uremic patients than in normal subjects, and the appearance of the inhibitor in serum and urine of uremic patients should be independent of the concurrent patterns of sodium excretion.
In the present studies, urine from chronically uremic patients and from normal subjects was examined for the presence of the natriuretic factor. In addition, assays for the presence of the factor were performed on urine and/or serum fractions from eight patients with advanced chronic renal disease and uremia who were nephrotic and edematous.
The Journal of Clinical Investigation Volume .53 June 1974 1559-1567 METHODS Assays of urine from Uremnic patients. Urine samples were collected quantitatively, generally for pericds of 24 h in glass or plastic containers maintained at 4°C. The samples were frozen as soon as the collections were completed. Within 24-72 h of collection, the total volume was concentrated 10-15-fold in a stainless steel container by lyophilization (model 5012 freeze-dryer, Refrigeration for Science, Inc., Island Park, N. Y.) and stored in plastic bottles at -80'C in an ultracold cabinet (model UC 105, Kelvinator Commercial Products, Inc., Manitowoc, Wis.). Then samples of the concentrate were thawed at room temperature, centrifuged at 4°C to discard any precipitate, and fractionated by column chromatography in a manner identical to that *described previously for the fractionation of serum samples (2) . In brief, 25-ml aliquots of the concentrated urines, equivalent to 5-h samples of original urine, were applied to individual 2.5 X 95-cm columns packed with Sephadex G-25 (fine grade, Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). Elution was carried out at 4°C by gravity at a rate of 55-65 ml/h with a solution of. 10 mM ammonium acetate at pH 6.8. The effluent solution was collected overnight in 18 X 150-mm glass tubes using an automated fraction -collector (model 7000 Ultrorac, LKB Producter AB, Stockholm, Sweden). On the basis of the ultraviolet absorption at 280 nm (LKB Uvicord) and of the electrical conductivity (model 5300B Conductolyzer with 5312B Conductivity cell, LKB Producter AB) tracings, the effluent solution and the contents of the tubes were pooled into several different fractions. The fraction containing the principal peaks of sodium, potassium, urea, and creatinine was discarded. As in the case with the serum samples, of several fractions eluted before and after the salt peak, natriuretic activity was contained only in the fraction appearing immediately after the salt peak (3) . Only this portion of the effluent solution was then routinely prepared by pooling the contents of 10 consecutive tubes (120 ml total) starting with the tube in which -the specific conductance of the eluate had returned to base-line values and lyophilizing to dryness overnight in a glass container.
The dried eluate was then carefully dissolved in 2.5 ml of distilled water, transferred into a screw cap glass or polyethylene counting vial, and stored at -80'C until the day of assay. Each milliliter of this solution was equivalent to the volume of original urine excreted in approximately 2 h. Storage of the concentrated urine samples or of the final fraction for periods of up to several months was found to have no influence on the natriuretic activity of the material.
The standard fractions, whether obtained from uremic patients or normal subjects, typically contained less than 10 meq/liter of sodium and 1 meq/liter of potassium. Differences were-not observed between fractions from uremic patients and normal subjects for ammonium, urea, and protein concentrations. The mean values were: ammonium, 24.4±3.7 meq/liter; urea, 15.8±2.6 mg/100 ml; and protein, 2.0+0.6 mg/ml.
The day of assay the sample was thawed, adjusted to a pH of 7.4, and to sodium and potassium concentrations of 140 and 4 meq/liter, respectively. All samples were prepared in a separate laboratory and the investigator performing the bioassay had no knowledge of the nature of the sample being tested. The assays for natriuretic activity were performed on female Sprague-Dawley rats weighing from 180 to 270 g.
The assay rats had a reduced glomerular filtration rate (GFR) and were given 0.2%o NaCl to drink for 2 days before performance of an assay. The rationale for using this model relates to the observation that, although the natriuretic factor from human urine has been found to produce a natriuretic response in normal hydropenic rats, the sensitivity of salt-loaded rats with a reduced nephron population to the factor appears increased substantially (4) . The details of the assay procedure have been described previously (3) . In brief, between 8:00 and 9:00 a.m. the rats were anesthetized lightly with ether to permit the insertion of catheters into the urinary bladder, one femoral artery, and a jugular vein. The rats were then placed in a plastic restraining device and allowed to recover from the anesthesia. No At least six control clearance periods ranging from 10 to 20 min in duration were obtained. After the fourth period, the control phase was terminated as soon as two consecutive clearance periods were obtained in which urine flow rate varied by less than 10%o. The test solution consisting of either a urine fraction from a uremic patient or the comparable urine fraction from a normal subject was administered intravenously, generally between 1:00 and 2:00 p.m., in a volume of no greater than 1 ml at a rate of 100 jul/min. With the exception of the dose-response studies described in the text, the amount of the fraction administered was harvested from the volume of original urine excreted in 126+15 min for the uremic subjects and 115±10 min for the normal subjects. These two values do not differ significantly. At the completion of the infusion, clearance periods of 10 min duration were resumed and continued for 60 min.
Arterial blood samples were collected during each clearance period for the determination of hematocrit and plasma inulin activity. Sodium and potassium concentrations were determined three times during each experiment (3). In representative experiments, arterial blood pressure of the assay animal was measured during and after infusion of the urine fraction. As in the previous experiments with the serum fractions, no change in blood pressure was detected either in the animals receiving the uremic fractions or in those receiving the normal fractions.
If evidence of intermittent obstruction to urine flow, leakage of urine around the catheter, or gross hematuria occurred, the experiment was terminated. The same criteria were employed in these studies as in the previous studies for the rejection of a completed experiment (3). These included: (a) UNaV in the assay rat of less than 1 or greater than 12 4eq/min during the control clearance peri-'Abbreviations used in this paper: FENa, fractional sodium excretion; UNaV, absolute sodium excretion. ods; or (b) a change in UNaV of greater than 20% between the penultimate and the final control clearance period. Five experiments were discarded because of these criteria. As in our previous study with the serum fractions, in all experiments the values for GFR, UNaV, and FENa during the last two control periods were averaged and compared with the mean of the six consecutive 10-min clearance periods obtained after infusion of the test solution (3) .
The first part of the study involved the comparison of urine fractions from chronically uremic patients with those from normal subjects. Urines were obtained from 17 patients with far advanced chronic renal disease. Endogenous creatinine clearance values were less than 20 ml/min in all patients and the average was 8.7±1.4 ml/min; the mean value for blood urea nitrogen (BUN) was 107±7 mg/100 ml; and FENa averaged 5.7±0.8%. Clinically, all of the patients, with one exception discussed below, were in external sodium balance. None of the uremic patients had congestive heart failure and none were on chronic dialysis.
For comparison, urines were obtained from 14 normal subjects (physicians and laboratory personnel). All were on an ad lib. salt intake. For several uremic patients andnormal subjects, more than one study was performed using the same or different urine samples collected under the same clinical conditions.
One patient (no. 14, Table II ) with a GFR of approximately 4 ml/min was studied under two very different clinical circumstances. He was admitted to the hospital after a prolonged period of anorexia, nausea, and vomiting. The first urine sample was collected when the patient was volume depleted, and had a FEN. of 1.2%o. Thereafter extracellular fluid volume was restored to normal and the To study the dose-response relationships, uremic or normal fractions obtained from several columns were pooled, relyophilized to dryness, and diluted in a volume of distilled water which provided either a 5-or a 10-fold increase in concentration over the standard preparation. The assays were performed by first infusing 0.1 ml (of the 10-fold concentrate) or 0.2 ml (of the 5-fold concentrate). 1 h later, after the completion of six 10-min clearance periods, 1 ml of the same preparation was administered and six additional periods were obtained.
Studies on nephrotic patients. These studies consisted of examination of the serum fraction from eight patients with far advanced chronic renal disease (mean GFR, 4.3 +0.6 ml/min) who were nephrotic. All were markedly edematous, had a serum albumin of 3 g/100 ml or less, and were excreting greater than 5 g of protein/day. The urine fraction was also assayed in three of these patients. The preparation and bioassay of the serum fraction were performed in accordance with the methods and techniques previously described (3). The patients in both the nonnephrotic uremic and nephrotic uremic groups who were receiving either digitalis glycosides or a diuretic preparation are designated in Tables II and IV Tables I  and II, respectively. The change in GFR after both normal and uremic fractions was small, inconsistent in direction, and not statistically significant; nor was there a significant difference between the change in GFR between the two groups. UNaV increased by a mean of 0.53 The sequential assays on a patient studied first with extracellular fluid volume depletion and again after volume repletion are included in Table II as experiment 14a and b. In the intial assay, both UNaV and FENa decreased slightly. In the second assay, the changes in UNaV and FENa averaged + 1.54 teq/min and + 1.55%, respectively.
The difference between the response to the uremic fractions and normal fractions could not be related to a difference in net fluid balance during the course of the experiments. The data referable to external fluid balance in both groups of assay rats are shown in Table  III . The total infusion rates were closely comparable in the two groups. However, in the rats receiving the normal fractions, urine flow rates were essentially equal to the infusion rates whereas, in the rats receiving the uremic fractions, urine flow rates exceeded the infusion rates before and after administration of the test solution. Thus, the natriuresis occurred with the uremic fractions despite negative fluid balance in the assay rats.
Dose-response experiments using normal and uremic fractions are shown in Fig. 4 . With the uremic fraction, the initial dose, equivalent to 49 min of urine, was administered in a volume of 0.1 ml. UNaV during the six postinfusion clearance periods increased by a mean of 1.82 geq/min over the control value. 1 FIGURE 3 Mean changes in UNaV, FENa, and GFR, expressed as percent of control values, for each of the six clearance periods after infusion of urine fractions from normal subjects (stippled bars) and from chronically uremic patients (hatched bars). Significant differences between the responses to the normal fractions and the uremic fractions are indicated as (*) for P < 0.02, (**) for P < 0.005, and (***) for P < 0.001. Each clearance period was of 10 min duration. min) was then administered. UNaV rose to a peak of 19 Aseq/min in the second post-infusion period. Values then fell sharply presumably because no fluid replacement was given and the rat became markedly volume depleted and sustained a substantial fall in GFR. The administration of 0.2 ml of urine fraction from a normal subject (obtained from the urine excreted in 93 min) produced no increase in UNaV. With the injection of 1 ml of the same fraction (equivalent to urine excreted during 465 min), UNaV increased from a mean value of 3.6 /Aeq/min during the control periods to a peak of 7.1 Aeq/min during the second postinfusion period.
Changes in FEN. for these experiments are also shown in Fig. 4 . With the uremic fraction FENa in- Fluid balance represents the difference between the infusion rate and the urine flow rate. Control and experimental periods are defined in Table I . The values correspond to those for the same control and experimental periods presented in Tables I and II . creased from 2.8% to mean values of 3.8% after the first infusion and 5.2% after the second infusion. The peak value for FEN. was 12.8%. With -the normal fraction mean FENa values changed from 2.9 to 1.9% and then to 3.4%. The peak value for FENa after the second infusion was 5.6%. The mean values for FEN. in four dose-response experiments using uremic fractions were 2.9% (control), 3.5% (first injection), and 4.9% (second injection). Studies on nephrotic patients. Table IV presents the results of 12 experiments from the eight patients with the nephrotic syndrome. Serum fractions were infused in nine studies and urine fractions in three. UNaV and FENa did not increase significantly in 10 studies using the fractions from 7 of the 8 patients. The serum fraction from the eighth patient increased UNaV by a mean of 1.85 ueq/min and FENa by a mean of 1.94%. The urine fraction from the same patient also produced an in- The approximate molecular weight of the serum natriuretic factor was estimated to be between 500 and 3,000 the basis of its ultrafiltration characteristics (2) . Thus, the factor could be filterable and might be excreted in the urine.
The present data document the presence of a natriuretic factor in the urine of patients with chronic uremia who were in external sodium balance on an unrestricted salt intake and who had appropriately high rates of FEN.. The degree of natriuresis produced in the assay rats using the amount of fraction harvested from an average of a 2-h urine sample was equivalent to that obtained from 10 ml of uremic serum.
In contrast, the same gel filtration fraction of urine from normal individuals failed to produce a significant increase in either UNaV or FENa in the assay rats. Moreover, for both parameters of sodium excretion, the differences between normal and uremic fractions were highly significant.
Several points of evidence suggest that the inhibitor obtained in urine may be identical to that observed in serum. Both active fractions have the same elution characteristics in the gel filtration system employed, appearing after the major peaks of sodium, potassium, urea, and creatinine. Both are heat stable and resist' refrigeration at -80'C. Both inhibit transcellular sodium transport by the urinary bladder of the toad (2, 6) , when added to the serosal surface but neither affects sodium transport when added to the mucosal surface (2, 6) . Finally, both are inactivated by leucine amino peptidase (7, 8 ).
Thus, the elevated level of the natriuretic factor in the serum of chronically uremic patients exists in the face of excretion rates in the urine which are also increased in relation to normal subjects. This observation is inconsistent with the thesis that the material is retained in the blood due to failure of its excretion. Rather, it indicates that the natriuretic factor is produced in greater quantities in the uremic patients and/ or that its rate of inactivation is diminished.
The second major question which was addressed in these studies concerns the relationship between the patterns of sodium excretion in chronic uremia and the activity of the natriuretic factor. If the factor is unrelated to the control system for the regulation of sodium excretion, its presence in serum and its excretion in urine of chronically uremic patients should be independent of the intensity of the natriuretic state. The availability of a group of eight patients with advanced uremia who had the nephrotic syndrome and were in a sodium-retaining state provided a unique opportunity to examine this question. The mean GFR in these patients was 4.3 ml/min and the mean BUN was 136 mg/100 ml. Despite the high grade uremia, no natriuretic activity could be demonstrated in the fractions from seven of the eight patients with the nephrotic syndrome. In the one patient with positive serum and urine assays a spontaneous natriuresis of major proportion took place shortly after the urine sample was collected.2 The observations made with the two urine fractions from the uremic patient who was studied first with a' FENa of 1.2% and again, 30 days later, with a FENa of 8.3% lend further support to the view that there is a relationship between the activity of the natriuretic factor and the concurrent patterns of so-2 Since these studies were completed a second patient with the nephrotic syndrome and a GFR of 15 ml/min has been observed to develop a spontaneous diuresis with the loss of 10 kg of edema fluid. In the midst of his natriuretic state, his urine was assayed and found to be strongly positive.
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J. J. Bourgoignie, K. H. Hwang, E. Ipakchi, and N. S. Bricker dium excretion. Finally, in studies by Schmidt, Bourgoignie, and Bricker (9), which will be reported separately, it was found that dogs subjected to experimental reduction of renal mass demonstrated the presence of the circulating inhibitor of sodium transport at low GFR if sodium intake was maintained constant throughout; however, if sodium intake was decreased in exact proportion to the decrement in GFR, such that FENa remained at less than 1% throughout, no natriuretic activity could be detected.
The composite data are consistent with the view that the circulating inhibitor of sodium transport present in chronically uremic patients cannot be explained by a failure of excretion. Rather it appears to be produced in increased amounts and/or to be degraded at a decreased rate. The inhibitor also seems to appear in the serum and urine only when uremic patients exhibit an increased rate of sodium excretion per nephron and it is not detectable when uremia is associated with a sodium-retaining state.
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